Floatz logo

CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-

Schizoaffective Disorder, Bipolar Type

Medical University of South CarolinaSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Schizoaffective Disorder, Bipolar Type cohort.

Asset / SponsorPhaseRating
17.BETA.-(1-KETOETHYL)-.DELTA. SUP(5)-ANDROSTEN-3.BETA.-OL
Sherwood Brown, MD, PhD
Phase 4BB

Same molecule, other indications

CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- is also rated in:

diabetic neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
Neuralgia, PostherpeticDormant
BBB
Indicative ·
77 / 100
View asset →
focal epilepsyDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →